$0.04
40.98% yesterday
Nasdaq, Nov 15, 09:41 pm CET
ISIN
US89237H1005
Symbol
TCON
Sector
Industry

TRACON Pharmaceuticals, Inc. Target price 2024 - Analyst rating & recommendation

TRACON Pharmaceuticals, Inc. Classifications & Recommendation:

Buy
50%
Hold
50%

TRACON Pharmaceuticals, Inc. Price Target

Target Price $6.00
Price $0.04
Potential
Number of Estimates 1
1 Analyst has issued a TRACON Pharmaceuticals, Inc. price target 2025. The average TRACON Pharmaceuticals, Inc. target price is $6.00. This is higher than the current stock price.
A rating was issued by 2 analysts: 1 Analysts recommend TRACON Pharmaceuticals, Inc. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the TRACON Pharmaceuticals, Inc. stock has an average upside potential 2025 of . Most analysts recommend the TRACON Pharmaceuticals, Inc. stock at Buy or hold.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Revenue Million $ 12.05 0.10
99.17%
Net Margin -61.97% -8,724.80%
13,978.10%

1 Analyst has issued a sales forecast TRACON Pharmaceuticals, Inc. 2024 . The average TRACON Pharmaceuticals, Inc. sales estimate is

$100k
Unlock
. This is
96.88% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$100k 96.88%
Unlock
, the lowest is
$100k 96.88%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $12.1m
2024
$100k 99.17%
Unlock
2025
$0.0 100.00%
Unlock

The average TRACON Pharmaceuticals, Inc. net profit estimate is

$-8.7m
Unlock
. This is
167.47% lower
Unlock
than the net profit for the last 12 months(TTM).

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-7.5m 57.55%
2024
$-8.7m 16.77%
Unlock
2025
$-4.6m 47.25%
Unlock

Net Margin

2023 -61.97%
2024
-8,724.80% 13,978.10%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share $ -2.19 -3.28
57.55% 49.77%
P/E negative
EV/Sales negative

The average TRACON Pharmaceuticals, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-3.28
Unlock
. This is
186.54% lower
Unlock
than earnings per share in the financial year 2023.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-2.19 57.55%
2024
$-3.28 49.77%
Unlock
2025
$-1.73 47.26%
Unlock

P/E ratio

Current 0.01 102.56%
2024
-0.20 2,100.00%
Unlock
2025
-0.38 90.00%
Unlock

Based on analysts' sales estimates for 2024, the TRACON Pharmaceuticals, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

-62.00
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
16.90
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -1.92 2,300.00%
2024
-62.00 3,129.17%
Unlock

P/S ratio

Current 0.04 95.23%
2024
16.90 44,966.67%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today